Bain Capital Life Sciences Investors, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001703031 · Show all filings

Period: Q3 2024 (← Previous) (Next →)

Filing Date: Nov 14, 2024

Total Value: $961M (100.0% shares, 0.0% debt)

Holdings (24)

NUVL NUVALENT INC 28.7%
Value $276M Shares 2,697,267 Est. Cost $28.96 Unrealized +186.4%
NAMS NEWAMSTERDAM PHARMA COMPANY 18.1%
Value $174M Shares 10,473,913 Est. Cost $10.64 Unrealized +62.6%
IRON DISC MEDICINE INC 9.2%
Value $88.24M Shares 1,795,735 Est. Cost $25.40 Unrealized +84.9%
DNTH DIANTHUS THERAPEUTICS INC 8.6%
Value $82.51M Shares 3,013,423 Est. Cost $21.73 Unrealized +28.2%
SVRA SAVARA INC 6.4%
Value $61.76M Shares 14,565,457 Est. Cost $1.94 Unrealized +128.1%
PHVS PHARVARIS N V 6.4%
Value $61.18M Shares 3,303,381 Est. Cost $23.89 Unrealized -23.5%
ANNX ANNEXON INC 5.2%
Value $50.02M Shares 8,449,748 Est. Cost $11.24 Unrealized -47.2%
SLDB SOLID BIOSCIENCES INC 2.9%
Value $28.12M Shares 4,034,582 Est. Cost $7.18 Unrealized +12.9%
TNGX TANGO THERAPEUTICS INC 2.2%
Value $20.88M Shares 2,712,008 Est. Cost $10.01 Unrealized -4.7%
KYTX KYVERNA THERAPEUTICS INC 1.7%
Value $16.47M Shares 3,368,370 Est. Cost $27.08 Unrealized -71.5%
MERSANA THERAPEUTICS INC 1.7%
Value $16.37M Shares 8,663,673 Est. Cost $12.65 Unrealized
CABA CABALETTA BIO INC 1.4%
Value $13.03M Shares 2,760,888 Est. Cost $8.83 Unrealized -34.5%
X4 PHARMACEUTICALS INC 1.2%
Value $11.32M Shares 16,915,784 Est. Cost $2.56 Unrealized
IPSC CENTURY THERAPEUTICS INC 1.0%
Value $9.252M Shares 5,410,361 Est. Cost $3.16 Unrealized -38.0%
AVIR ATEA PHARMACEUTICALS INC 0.9%
Value $8.327M Shares 2,485,638 Est. Cost $32.23 Unrealized -88.8%
CIDARA THERAPEUTICS INC 0.8%
Value $7.558M Shares 703,080 Est. Cost $10.75 Unrealized
RPID RAPID MICRO BIOSYSTEMS INC 0.8%
Value $7.507M Shares 8,434,560 Est. Cost $20.66 Unrealized -96.2%
CCCC C4 THERAPEUTICS INC 0.7%
Value $6.338M Shares 1,111,910 Est. Cost $29.00 Unrealized -79.2%
SYRS SYROS PHARMACEUTICALS INC 0.6%
Value $5.913M Shares 2,750,151 Est. Cost $5.62 Unrealized -36.1%
NAUT NAUTILUS BIOTECHNOLOGY INC 0.6%
Value $5.7M Shares 2,000,000 Est. Cost $10.83 Unrealized -76.1%
MARINUS PHARMACEUTICALS INC 0.5%
Value $4.74M Shares 2,693,380 Est. Cost $8.67 Unrealized
XLO XILIO THERAPEUTICS INC 0.4%
Value $3.597M Shares 4,566,817 Est. Cost $10.85 Unrealized -91.9%
IVVD INVIVYD INC 0.2%
Value $1.836M Shares 1,799,595 Est. Cost $37.11 Unrealized -97.1%
NAMSW NEWAMSTERDAM PHARMA COMPANY 0.1%
Value $700K Shares 100,000 Est. Cost $0.86 Unrealized